JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT revenue for the last year amounted to 2.24 B CNY, the most of which — 1.85 B CNY — came from its highest performing source at the moment, Medicine, the year earlier bringing 1.42 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT 2.24 B CNY, and the year before that — 2.03 B CNY.